AU Stock MarketDetailed Quotes
1AI Algorae Pharmaceuticals Ltd
- 0.008
- +0.001+14.29%
20min DelayMarket Closed Nov 29 16:00 AET
13.50MMarket Cap-8000P/E (Static)
0.009High0.007Low12.99MVolume0.007Open0.007Pre Close100.45KTurnover0.01352wk High1.24%Turnover Ratio1.69BShares0.00552wk Low-0.001EPS TTM8.36MFloat Cap0.016Historical HighLossP/E (Static)1.05BShs Float0.005Historical Low-0.001EPS LYR28.57%Amplitude--Dividend TTM4.00P/B1Lot Size--Div YieldTTM
Algorae Pharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|
| Total revenue | -67.57%3.17K | 9.77K | ||||
| Operating revenue | ---- | ---- | ---- | ---- | -67.57%3.17K | --9.77K |
| Cost of revenue | ||||||
| Gross profit | -67.57%3.17K | 9.77K | ||||
| Operating expense | 3.32%2.2M | -10.38%2.13M | 4.08%2.38M | -27.87%2.28M | -24.12%3.17M | 4.17M |
| Selling and administrative expenses | --1.31M | ---- | ---- | ---- | ---- | ---- |
| -General and administrative expense | --1.31M | ---- | ---- | ---- | ---- | ---- |
| Research and development costs | -82.74%226.07K | -10.49%1.31M | -9.08%1.46M | -32.49%1.61M | -28.39%2.38M | --3.33M |
| Depreciation amortization depletion | ---- | -25.03%557 | -84.45%743 | -71.65%4.78K | -67.78%16.85K | --52.3K |
| -Depreciation and amortization | ---- | -25.03%557 | -84.45%743 | -71.65%4.78K | -67.78%16.85K | --52.3K |
| Other operating expenses | -19.17%662.69K | -10.19%819.89K | 36.34%912.92K | -12.51%669.61K | -3.23%765.32K | --790.89K |
| Operating profit | -3.32%-2.2M | 10.38%-2.13M | -4.08%-2.38M | 27.80%-2.28M | 24.01%-3.16M | -4.16M |
| Net non-operating interest income (expenses) | 197.98%125.2K | 1,133.95%42.02K | -55.20%3.41K | -86.33%7.6K | -54.88%55.61K | 123.25K |
| Non-operating interest income | 197.98%125.2K | 1,133.95%42.02K | -55.20%3.41K | -86.33%7.6K | -54.88%55.61K | --123.25K |
| Other net income (expenses) | 0.70%-20.04K | -3,360.10%-20.18K | -99.83%619 | -79.04%365.79K | 242.65%1.74M | 509.26K |
| Special income (charges) | ---2.11K | ---- | ---12.31K | ---- | ---148.2K | ---- |
| -Gain on sale of property,plant,equipment | ---2.11K | ---- | ---12.31K | ---- | ---148.2K | ---- |
| Other non-operating income (expenses) | 11.15%-17.93K | -256.12%-20.18K | -96.47%12.93K | -80.68%365.79K | 271.75%1.89M | --509.26K |
| Income before tax | 0.57%-2.1M | 11.15%-2.11M | -24.49%-2.37M | -41.63%-1.91M | 61.31%-1.35M | -3.48M |
| Income tax | 0 | 0 | 6.77%-414.73K | -18.02%-444.86K | -27.27%-376.92K | -296.15K |
| Earnings from equity interest net of tax | ||||||
| Net income | 0.57%-2.1M | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | -3.18M |
| Net income continuous operations | 0.57%-2.1M | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | ---3.18M |
| Noncontrolling interests | ||||||
| Net income attributable to the company | 0.57%-2.1M | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | -3.18M |
| Preferred stock dividends | ||||||
| Other under preferred stock dividend | ||||||
| Net income attributable to common stockholders | 0.57%-2.1M | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | -3.18M |
| Diluted earnings per share | 18.75%-0.0013 | 26.37%-0.0016 | 11.45%-0.0022 | -52.99%-0.0025 | 69.65%-0.0016 | -0.0053 |
| Basic earnings per share | 18.75%-0.0013 | 26.37%-0.0016 | 11.45%-0.0022 | -52.99%-0.0025 | 69.65%-0.0016 | -0.0053 |
| Dividend per share | ||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data